Axsome Therapeutics Inc (NASDAQ: AXSM) is 5.51% higher on its value in year-to-date trading and has touched a low of $64.11 and a high of $105.00 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The AXSM stock was last observed hovering at around $80.05 in the last trading session, with the day’s gains setting it 9.22%.
Currently trading at $89.27, the stock is 1.94% and -3.21% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 1.88 million and changing 11.52% at the moment leaves the stock 5.71% off its SMA200. AXSM registered 0.08% gain for a year compared to 6-month gain of 7.77%. The firm has a 50-day simple moving average (SMA 50) of $92.2505 and a 200-day simple moving average (SMA200) of $84.386475.
The stock witnessed a -9.66% loss in the last 1 month and extending the period to 3 months gives it a 7.45%, and is 3.26% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 5.39% over the week and 5.00% over the month.
Axsome Therapeutics Inc (AXSM) has around 545 employees, a market worth around $4.33B and $338.46M in sales. Profit margin for the company is -91.87%. Distance from 52-week low is 39.25% and -14.98% from its 52-week high. The company has generated returns on investments over the last 12 months (-110.15%).
with sales reaching $117.63M over the same period.The EPS is expected to shrink by -3.06% this year, but quarterly earnings will post 42.01% year-over-year. Quarterly sales are estimated to grow 64.45% in year-over-year returns.
Axsome Therapeutics Inc (AXSM) Top Institutional Holders
381.0 institutions hold shares in Axsome Therapeutics Inc (AXSM), with institutional investors hold 97.34% of the company’s shares. The shares outstanding are 48.44M, and float is at 39.60M with Short Float at 16.71%. Institutions hold 81.08% of the Float.
The top institutional shareholder in the company is RTW INVESTMENTS, LP with over 4.63 million shares valued at $373.06 million. The investor’s holdings represent 9.7784% of the AXSM Shares outstanding. As of 2024-06-30, the second largest holder is VANGUARD GROUP INC with 3.74 million shares valued at $301.23 million to account for 7.8956 of the shares outstanding. The other top investors are BLACKROCK INC. which holds 3.3 million shares representing 6.963% and valued at over $265.65 million, while FAIRMOUNT FUNDS MANAGEMENT LLC holds 4.9797 of the shares totaling 2.36 million with a market value of $189.99 million.
Axsome Therapeutics Inc (AXSM) Insider Activity
The most recent transaction is an insider sale by Saad Mark E, the company’s Director. SEC filings show that Saad Mark E sold 11,016 shares of the company’s common stock on Sep 11 ’24 at a price of $91.31 per share for a total of $1.01 million. Following the sale, the insider now owns 10002.0 shares.
Still, SEC filings show that on Aug 09 ’24, Jacobson Mark L. (Chief Operating Officer) disposed off 47,739 shares at an average price of $84.26 for $4.02 million. The insider now directly holds 5,783 shares of Axsome Therapeutics Inc (AXSM).
